The Global HIV/AIDS Timeline is an ongoing reference tool for the many political, scientific, cultural, and community developments that have occurred over the history of the HIV/AIDS epidemic.
- view as grid
- view as list
Despite significant successes in addressing HIV/AIDS around the world, including in the United States, many challenges remain—there are more people living with HIV than ever before and millions of new infections each year, and not everyone has access to the care and treatment they need. At the same time, there…
Kaiser/UNAIDS Study Finds Donor Government Funding for HIV Rose to US$8.1 Billion in 2017 due to Shift in Timing of U.S. Support
Donor government disbursements to combat HIV in low- and middle-income countries increased 16 percent from US$7 billion in 2016 to US$8.1 billion in 2017 – though the higher total stems largely from the timing of U.S. funding and is not expected to last, a new report from the Kaiser Family Foundation…
This report, Financing the Response to AIDS in Low- and Middle-Income Countries: International Assistance from Donor Governments in 2016, tracks funding levels of the donor governments that collectively provide the bulk of international assistance for AIDS through bilateral programs and contributions to the Global Fund to Fight AIDS, Tuberculosis and Malaria. The new report, produced as a partnership between the Kaiser Family Foundation and UNAIDS, provides the latest data available on donor funding disbursements based on data provided by governments. It includes their bilateral assistance to low- and middle-income countries and contributions to the Global Fund as well as UNITAID.
This resource tracks states with approved Section 1115 Medicaid waivers and pending waivers (which include new waiver applications, waiver amendments, and renewals). View approved and pending waivers according to waiver category. Related waiver resources are available by topic at the bottom of the page, as are additional details on each approved and pending waiver.
On July 10, 2018, CMS released the funding announcement for the federal marketplace Navigators for 2018-2019, which reduced funding to $10 million. This brief reviews data presented by CMS as well as other data sources to assess the work and effectiveness of Navigators.
This interactive map shows the status of all Section 1332 waivers requested by states. The Affordable Care Act (ACA) allows states to apply for innovation waivers to alter key ACA requirements in the individual and small group insurance markets and can be used to shore up fragile insurance markets, address unique state insurance market issues, or experiment with alternative models of providing coverage to state residents.
In this Axios column, Drew Altman examines the potential implications of the Kentucky Medicaid waiver case for other states and future waivers.